These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20881438)

  • 41. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure.
    Kerbaul F; Gariboldi V; Giorgi R; Mekkaoui C; Guieu R; Fesler P; Gouin F; Brimioulle S; Collart F
    Crit Care Med; 2007 Aug; 35(8):1948-54. PubMed ID: 17568324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial.
    Pellicer A; Valverde E; Elorza MD; Madero R; Gayá F; Quero J; Cabañas F
    Pediatrics; 2005 Jun; 115(6):1501-12. PubMed ID: 15930210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levosimendan vs. intra-aortic balloon pump in high-risk cardiac surgery.
    Lomivorotov VV; Cherniavskiy AM; Boboshko VA; Kornilov IA; Lomivorotov VN; Karaskov AM
    Asian Cardiovasc Thorac Ann; 2011 Apr; 19(2):154-9. PubMed ID: 21471262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of acute heart failure in an infant after cardiac surgery using levosimendan.
    Braun JP; Schneider M; Kastrup M; Liu J
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):228-30. PubMed ID: 15201012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of levosimendan in children].
    Séguéla PE; Tafer N; Thambo JB; Mauriat P
    Arch Pediatr; 2016 Aug; 23(8):848-56. PubMed ID: 27369103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levosimendan: implications for clinicians.
    McBride BF; White CM
    J Clin Pharmacol; 2003 Oct; 43(10):1071-81. PubMed ID: 14517189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.
    Branzi G; Malfatto G; Villani A; Ciambellotti F; Revera M; Giglio A; Rosa FD; Facchini M; Parati G
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levosimendan and cardiac surgery.
    De Santis V; Vitale D; Tritapepe L
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):210. PubMed ID: 19264513
    [No Abstract]   [Full Text] [Related]  

  • 49. Can pulmonary artery hypertension be attributed to levosimendan? A problematic based on a patient's case.
    Tagarakis GI; Baddour AJ; Tsilimingas NB
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):552-3. PubMed ID: 20035233
    [No Abstract]   [Full Text] [Related]  

  • 50. Levosimendan--an inoprotective drug or much ado about nothing?
    Lehmann A; Radke J; Sack FU
    Crit Care Med; 2011 Oct; 39(10):2365-6. PubMed ID: 21926495
    [No Abstract]   [Full Text] [Related]  

  • 51. Enteroviral myocarditis requiring extracorporeal membranous oxygenation in a 2 week old girl.
    Elisha N; Paret G; Rubinsthein M; Salem I
    Isr Med Assoc J; 2013 Jun; 15(6):319-20. PubMed ID: 23882903
    [No Abstract]   [Full Text] [Related]  

  • 52. Levosimendan for the Low Cardiac Output Syndrome after Cardiac Surgery.
    Desai AS; Jarcho JA
    N Engl J Med; 2017 May; 376(21):2076-2078. PubMed ID: 28538112
    [No Abstract]   [Full Text] [Related]  

  • 53. A Review of Systemic Vasodilators in Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery.
    Mills KI; Costello JM; Almodovar MC
    Curr Vasc Pharmacol; 2016; 14(1):29-36. PubMed ID: 26463987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Levo is in the air: take a deep breath!
    Ertmer C; Morelli A; Westphal M
    Crit Care Med; 2008 Jun; 36(6):1979-81. PubMed ID: 18520665
    [No Abstract]   [Full Text] [Related]  

  • 55. Managing Vasoactive Medications Following Cardiothoracic Surgery.
    Petty M; Kopp K
    Crit Care Nurs Clin North Am; 2019 Sep; 31(3):349-366. PubMed ID: 31351555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular Drug Therapy for Human Newborn: Review of Pharmacodynamic Data.
    Ergenekon E; Rojas-Anaya H; Bravo MC; Kotidis C; Mahoney L; Rabe H
    Curr Pharm Des; 2017; 23(38):5850-5860. PubMed ID: 28925895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The peripheral circulation and lactic acid metabolism in heart, or cardiovascular, failure.
    Wasserman K
    Circulation; 1989 Oct; 80(4):1084-6. PubMed ID: 2791237
    [No Abstract]   [Full Text] [Related]  

  • 58. Magnesium and heart failure.
    Delva P
    Mol Aspects Med; 2003; 24(1-3):79-105. PubMed ID: 12537991
    [No Abstract]   [Full Text] [Related]  

  • 59. An Update on Pharmacologic Management of Neonatal Hypotension: When, Why, and Which Medication.
    Agakidou E; Chatziioannidis I; Kontou A; Stathopoulou T; Chotas W; Sarafidis K
    Children (Basel); 2024 Apr; 11(4):. PubMed ID: 38671707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension.
    Schroeder L; Holcher S; Leyens J; Geipel A; Strizek B; Dresbach T; Mueller A; Kipfmueller F
    Eur J Pediatr; 2023 Jul; 182(7):3165-3174. PubMed ID: 37100959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.